PHARMATEKET ApS Financials, key figures and credit report
Gross profit -31.3 kDKK FY 2025 -9.2% vs 2024
EBIT -31.3 kDKK FY 2025 -9.2% vs 2024
Net debt -1 083.4 kDKK FY 2025 -56.3% vs 2024
Quick ratio 20.2 FY 2025 +18.2 vs 2024
Income statement (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| External services | -23.75 | -25.00 | -27.00 | -28.63 | -31.25 |
| Gross profit | -23.75 | -25.00 | -27.00 | -28.63 | -31.25 |
| EBIT | -23.75 | -25.00 | -27.00 | -28.63 | -31.25 |
| Other financial income | 1.78 | 0.09 | 12.54 | 6.47 | 11.78 |
| Other financial expenses | -3.54 | -40.26 | -3.01 | -76.75 | -16.47 |
| Net income from associates (fin.) | 244.67 | 293.12 | 708.67 | 422.94 | 225.95 |
| Pre-tax profit | 219.16 | 227.95 | 691.20 | 324.03 | 190.01 |
| Income taxes | 5.63 | 14.34 | 3.85 | 21.78 | 7.92 |
| Net earnings | 224.79 | 242.30 | 695.05 | 345.81 | 197.93 |
Assets (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Holdings in group member companies | 363.88 | 412.64 | 837.43 | 527.23 | 353.85 |
| Investments total | 363.88 | 412.64 | 837.43 | 527.23 | 353.85 |
| Long term receivables total | |||||
| Inventories total | |||||
| Current amounts owed by group member comp. | 182.20 | 393.97 | 717.86 | 43.56 | |
| Current deferred tax assets | 5.63 | 14.34 | 3.85 | 21.78 | 7.92 |
| Short term receivables total | 187.83 | 408.31 | 721.71 | 21.78 | 51.48 |
| Cash and bank deposits | 328.14 | 75.15 | 75.01 | 1 386.26 | 1 083.43 |
| Cash and cash equivalents | 328.14 | 75.15 | 75.01 | 1 386.26 | 1 083.43 |
| Balance sheet total (assets) | 879.85 | 896.10 | 1 634.14 | 1 935.28 | 1 488.76 |
Equity and liabilities (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Share capital | 200.00 | 200.00 | 200.00 | 200.00 | 200.00 |
| Shares repurchased | 650.00 | 1 000.00 | |||
| Other reserves | 220.90 | 269.66 | 694.45 | 384.25 | 210.87 |
| Retained earnings | -56.65 | 119.82 | - 683.60 | 287.24 | - 176.29 |
| Profit of the financial year | 224.79 | 242.30 | 695.05 | 345.81 | 197.93 |
| Shareholders equity total | 589.03 | 831.78 | 1 555.90 | 1 217.30 | 1 432.51 |
| Non-current liabilities total | |||||
| Current trade creditors | 25.00 | 25.00 | 25.00 | 25.00 | 25.00 |
| Current owed to group member | 265.82 | 34.32 | 48.24 | 692.97 | |
| Other non-interest bearing current liabilities | 5.00 | 5.00 | 0.01 | 31.25 | |
| Current liabilities total | 290.82 | 64.32 | 78.24 | 717.98 | 56.25 |
| Balance sheet total (liabilities) | 879.85 | 896.10 | 1 634.14 | 1 935.28 | 1 488.76 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated